A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
Int J Infect Dis. 2021 Feb;103:214-216. doi: 10.1016/j.ijid.2020.11.191. Epub 2020 Dec 2.
Int J Infect Dis. 2021.
PMID: 33278625
Free PMC article.
Clinical Trial.